カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

抗体薬物複合体の世界市場2022：アドセトリス、カドキュラ

■ 英語タイトル：Global Antibody-drug Conjugates Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22DC3747）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22DC3747
■ 発行日：2023年1月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：70
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥522,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥783,000見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,044,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[抗体薬物複合体の世界市場2022：アドセトリス、カドキュラ]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

世界の抗体薬物複合体市場レポートは、グローバル市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
Global Info Research社の最新のリサーチによると、世界の抗体薬物複合体の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

抗体薬物複合体市場はタイプとアプリケーションによって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメントは次をカバーします。
・アドセトリス、カドキュラ

アプリケーション別セグメントは次のように区分されます。
・乳がん、リンパ腫

世界の抗体薬物複合体市場の主要な市場プレーヤーは以下のとおりです。
・ImmunoGen、Seattle Genetics、Roche、Takeda

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・欧州（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南米（ブラジル、アルゼンチン、コロンビア）
・中東/アフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査資料の内容は計15章あります。
・第1章では、抗体薬物複合体製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な抗体薬物複合体メーカーの企業概要、2019年～2022年までの抗体薬物複合体の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な抗体薬物複合体メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別抗体薬物複合体の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの抗体薬物複合体の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での抗体薬物複合体市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および抗体薬物複合体の産業チェーンを掲載しています。
・第13、14、15章では、抗体薬物複合体の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
– 抗体薬物複合体の概要
– 種類別分析（2017年vs2021年vs2028年）：アドセトリス、カドキュラ
– 用途別分析（2017年vs2021年vs2028年）：乳がん、リンパ腫
– 世界の抗体薬物複合体市場規模・予測
– 世界の抗体薬物複合体生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– ImmunoGen、Seattle Genetics、Roche、Takeda
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：アドセトリス、カドキュラ
・用途別分析2017年-2028年：乳がん、リンパ腫
・抗体薬物複合体の北米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・抗体薬物複合体のヨーロッパ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・抗体薬物複合体のアジア市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・抗体薬物複合体の南米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・抗体薬物複合体の中東・アフリカ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Antibody-drug Conjugates Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antibody-drug Conjugates Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Adcetris
1.2.3 Kadcyla
1.3 Market Analysis by Application
1.3.1 Overview: Global Antibody-drug Conjugates Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Breast Cancer
1.3.3 Lymphoma
1.4 Global Antibody-drug Conjugates Market Size & Forecast
1.4.1 Global Antibody-drug Conjugates Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Antibody-drug Conjugates Sales in Volume (2017-2028)
1.4.3 Global Antibody-drug Conjugates Price (2017-2028)
1.5 Global Antibody-drug Conjugates Production Capacity Analysis
1.5.1 Global Antibody-drug Conjugates Total Production Capacity (2017-2028)
1.5.2 Global Antibody-drug Conjugates Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Antibody-drug Conjugates Market Drivers
1.6.2 Antibody-drug Conjugates Market Restraints
1.6.3 Antibody-drug Conjugates Trends Analysis
2 Manufacturers Profiles
2.1 ImmunoGen
2.1.1 ImmunoGen Details
2.1.2 ImmunoGen Major Business
2.1.3 ImmunoGen Antibody-drug Conjugates Product and Services
2.1.4 ImmunoGen Antibody-drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Seattle Genetics
2.2.1 Seattle Genetics Details
2.2.2 Seattle Genetics Major Business
2.2.3 Seattle Genetics Antibody-drug Conjugates Product and Services
2.2.4 Seattle Genetics Antibody-drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Antibody-drug Conjugates Product and Services
2.3.4 Roche Antibody-drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Takeda
2.4.1 Takeda Details
2.4.2 Takeda Major Business
2.4.3 Takeda Antibody-drug Conjugates Product and Services
2.4.4 Takeda Antibody-drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Antibody-drug Conjugates Breakdown Data by Manufacturer
3.1 Global Antibody-drug Conjugates Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Antibody-drug Conjugates Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Antibody-drug Conjugates
3.4 Market Concentration Rate
3.4.1 Top 3 Antibody-drug Conjugates Manufacturer Market Share in 2021
3.4.2 Top 6 Antibody-drug Conjugates Manufacturer Market Share in 2021
3.5 Global Antibody-drug Conjugates Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Antibody-drug Conjugates Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Antibody-drug Conjugates Market Size by Region
4.1.1 Global Antibody-drug Conjugates Sales in Volume by Region (2017-2028)
4.1.2 Global Antibody-drug Conjugates Revenue by Region (2017-2028)
4.2 North America Antibody-drug Conjugates Revenue (2017-2028)
4.3 Europe Antibody-drug Conjugates Revenue (2017-2028)
4.4 Asia-Pacific Antibody-drug Conjugates Revenue (2017-2028)
4.5 South America Antibody-drug Conjugates Revenue (2017-2028)
4.6 Middle East and Africa Antibody-drug Conjugates Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Antibody-drug Conjugates Sales in Volume by Type (2017-2028)
5.2 Global Antibody-drug Conjugates Revenue by Type (2017-2028)
5.3 Global Antibody-drug Conjugates Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Antibody-drug Conjugates Sales in Volume by Application (2017-2028)
6.2 Global Antibody-drug Conjugates Revenue by Application (2017-2028)
6.3 Global Antibody-drug Conjugates Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Antibody-drug Conjugates Sales by Type (2017-2028)
7.2 North America Antibody-drug Conjugates Sales by Application (2017-2028)
7.3 North America Antibody-drug Conjugates Market Size by Country
7.3.1 North America Antibody-drug Conjugates Sales in Volume by Country (2017-2028)
7.3.2 North America Antibody-drug Conjugates Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Antibody-drug Conjugates Sales by Type (2017-2028)
8.2 Europe Antibody-drug Conjugates Sales by Application (2017-2028)
8.3 Europe Antibody-drug Conjugates Market Size by Country
8.3.1 Europe Antibody-drug Conjugates Sales in Volume by Country (2017-2028)
8.3.2 Europe Antibody-drug Conjugates Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Antibody-drug Conjugates Sales by Type (2017-2028)
9.2 Asia-Pacific Antibody-drug Conjugates Sales by Application (2017-2028)
9.3 Asia-Pacific Antibody-drug Conjugates Market Size by Region
9.3.1 Asia-Pacific Antibody-drug Conjugates Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Antibody-drug Conjugates Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Antibody-drug Conjugates Sales by Type (2017-2028)
10.2 South America Antibody-drug Conjugates Sales by Application (2017-2028)
10.3 South America Antibody-drug Conjugates Market Size by Country
10.3.1 South America Antibody-drug Conjugates Sales in Volume by Country (2017-2028)
10.3.2 South America Antibody-drug Conjugates Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Antibody-drug Conjugates Sales by Type (2017-2028)
11.2 Middle East & Africa Antibody-drug Conjugates Sales by Application (2017-2028)
11.3 Middle East & Africa Antibody-drug Conjugates Market Size by Country
11.3.1 Middle East & Africa Antibody-drug Conjugates Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Antibody-drug Conjugates Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Antibody-drug Conjugates and Key Manufacturers
12.2 Manufacturing Costs Percentage of Antibody-drug Conjugates
12.3 Antibody-drug Conjugates Production Process
12.4 Antibody-drug Conjugates Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Antibody-drug Conjugates Typical Distributors
13.3 Antibody-drug Conjugates Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Antibody-drug Conjugates Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Antibody-drug Conjugates Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. ImmunoGen Basic Information, Manufacturing Base and Competitors
Table 4. ImmunoGen Major Business
Table 5. ImmunoGen Antibody-drug Conjugates Product and Services
Table 6. ImmunoGen Antibody-drug Conjugates Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Seattle Genetics Basic Information, Manufacturing Base and Competitors
Table 8. Seattle Genetics Major Business
Table 9. Seattle Genetics Antibody-drug Conjugates Product and Services
Table 10. Seattle Genetics Antibody-drug Conjugates Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Roche Basic Information, Manufacturing Base and Competitors
Table 12. Roche Major Business
Table 13. Roche Antibody-drug Conjugates Product and Services
Table 14. Roche Antibody-drug Conjugates Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Takeda Basic Information, Manufacturing Base and Competitors
Table 16. Takeda Major Business
Table 17. Takeda Antibody-drug Conjugates Product and Services
Table 18. Takeda Antibody-drug Conjugates Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Global Antibody-drug Conjugates Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Kg)
Table 20. Global Antibody-drug Conjugates Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 21. Market Position of Manufacturers in Antibody-drug Conjugates, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 22. Global Antibody-drug Conjugates Production Capacity by Company, (Kg): 2020 VS 2021
Table 23. Head Office and Antibody-drug Conjugates Production Site of Key Manufacturer
Table 24. Antibody-drug Conjugates New Entrant and Capacity Expansion Plans
Table 25. Antibody-drug Conjugates Mergers & Acquisitions in the Past Five Years
Table 26. Global Antibody-drug Conjugates Sales by Region (2017-2022) & (Kg)
Table 27. Global Antibody-drug Conjugates Sales by Region (2023-2028) & (Kg)
Table 28. Global Antibody-drug Conjugates Revenue by Region (2017-2022) & (USD Million)
Table 29. Global Antibody-drug Conjugates Revenue by Region (2023-2028) & (USD Million)
Table 30. Global Antibody-drug Conjugates Sales by Type (2017-2022) & (Kg)
Table 31. Global Antibody-drug Conjugates Sales by Type (2023-2028) & (Kg)
Table 32. Global Antibody-drug Conjugates Revenue by Type (2017-2022) & (USD Million)
Table 33. Global Antibody-drug Conjugates Revenue by Type (2023-2028) & (USD Million)
Table 34. Global Antibody-drug Conjugates Price by Type (2017-2022) & (USD/Kg)
Table 35. Global Antibody-drug Conjugates Price by Type (2023-2028) & (USD/Kg)
Table 36. Global Antibody-drug Conjugates Sales by Application (2017-2022) & (Kg)
Table 37. Global Antibody-drug Conjugates Sales by Application (2023-2028) & (Kg)
Table 38. Global Antibody-drug Conjugates Revenue by Application (2017-2022) & (USD Million)
Table 39. Global Antibody-drug Conjugates Revenue by Application (2023-2028) & (USD Million)
Table 40. Global Antibody-drug Conjugates Price by Application (2017-2022) & (USD/Kg)
Table 41. Global Antibody-drug Conjugates Price by Application (2023-2028) & (USD/Kg)
Table 42. North America Antibody-drug Conjugates Sales by Country (2017-2022) & (Kg)
Table 43. North America Antibody-drug Conjugates Sales by Country (2023-2028) & (Kg)
Table 44. North America Antibody-drug Conjugates Revenue by Country (2017-2022) & (USD Million)
Table 45. North America Antibody-drug Conjugates Revenue by Country (2023-2028) & (USD Million)
Table 46. North America Antibody-drug Conjugates Sales by Type (2017-2022) & (Kg)
Table 47. North America Antibody-drug Conjugates Sales by Type (2023-2028) & (Kg)
Table 48. North America Antibody-drug Conjugates Sales by Application (2017-2022) & (Kg)
Table 49. North America Antibody-drug Conjugates Sales by Application (2023-2028) & (Kg)
Table 50. Europe Antibody-drug Conjugates Sales by Country (2017-2022) & (Kg)
Table 51. Europe Antibody-drug Conjugates Sales by Country (2023-2028) & (Kg)
Table 52. Europe Antibody-drug Conjugates Revenue by Country (2017-2022) & (USD Million)
Table 53. Europe Antibody-drug Conjugates Revenue by Country (2023-2028) & (USD Million)
Table 54. Europe Antibody-drug Conjugates Sales by Type (2017-2022) & (Kg)
Table 55. Europe Antibody-drug Conjugates Sales by Type (2023-2028) & (Kg)
Table 56. Europe Antibody-drug Conjugates Sales by Application (2017-2022) & (Kg)
Table 57. Europe Antibody-drug Conjugates Sales by Application (2023-2028) & (Kg)
Table 58. Asia-Pacific Antibody-drug Conjugates Sales by Region (2017-2022) & (Kg)
Table 59. Asia-Pacific Antibody-drug Conjugates Sales by Region (2023-2028) & (Kg)
Table 60. Asia-Pacific Antibody-drug Conjugates Revenue by Region (2017-2022) & (USD Million)
Table 61. Asia-Pacific Antibody-drug Conjugates Revenue by Region (2023-2028) & (USD Million)
Table 62. Asia-Pacific Antibody-drug Conjugates Sales by Type (2017-2022) & (Kg)
Table 63. Asia-Pacific Antibody-drug Conjugates Sales by Type (2023-2028) & (Kg)
Table 64. Asia-Pacific Antibody-drug Conjugates Sales by Application (2017-2022) & (Kg)
Table 65. Asia-Pacific Antibody-drug Conjugates Sales by Application (2023-2028) & (Kg)
Table 66. South America Antibody-drug Conjugates Sales by Country (2017-2022) & (Kg)
Table 67. South America Antibody-drug Conjugates Sales by Country (2023-2028) & (Kg)
Table 68. South America Antibody-drug Conjugates Revenue by Country (2017-2022) & (USD Million)
Table 69. South America Antibody-drug Conjugates Revenue by Country (2023-2028) & (USD Million)
Table 70. South America Antibody-drug Conjugates Sales by Type (2017-2022) & (Kg)
Table 71. South America Antibody-drug Conjugates Sales by Type (2023-2028) & (Kg)
Table 72. South America Antibody-drug Conjugates Sales by Application (2017-2022) & (Kg)
Table 73. South America Antibody-drug Conjugates Sales by Application (2023-2028) & (Kg)
Table 74. Middle East & Africa Antibody-drug Conjugates Sales by Region (2017-2022) & (Kg)
Table 75. Middle East & Africa Antibody-drug Conjugates Sales by Region (2023-2028) & (Kg)
Table 76. Middle East & Africa Antibody-drug Conjugates Revenue by Region (2017-2022) & (USD Million)
Table 77. Middle East & Africa Antibody-drug Conjugates Revenue by Region (2023-2028) & (USD Million)
Table 78. Middle East & Africa Antibody-drug Conjugates Sales by Type (2017-2022) & (Kg)
Table 79. Middle East & Africa Antibody-drug Conjugates Sales by Type (2023-2028) & (Kg)
Table 80. Middle East & Africa Antibody-drug Conjugates Sales by Application (2017-2022) & (Kg)
Table 81. Middle East & Africa Antibody-drug Conjugates Sales by Application (2023-2028) & (Kg)
Table 82. Antibody-drug Conjugates Raw Material
Table 83. Key Manufacturers of Antibody-drug Conjugates Raw Materials
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Antibody-drug Conjugates Typical Distributors
Table 87. Antibody-drug Conjugates Typical Customers
List of Figures
Figure 1. Antibody-drug Conjugates Picture
Figure 2. Global Antibody-drug Conjugates Revenue Market Share by Type in 2021
Figure 3. Adcetris
Figure 4. Kadcyla
Figure 5. Global Antibody-drug Conjugates Revenue Market Share by Application in 2021
Figure 6. Breast Cancer
Figure 7. Lymphoma
Figure 8. Global Antibody-drug Conjugates Revenue, (USD Million) & (Kg): 2017 & 2021 & 2028
Figure 9. Global Antibody-drug Conjugates Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Antibody-drug Conjugates Sales (2017-2028) & (Kg)
Figure 11. Global Antibody-drug Conjugates Price (2017-2028) & (USD/Kg)
Figure 12. Global Antibody-drug Conjugates Production Capacity (2017-2028) & (Kg)
Figure 13. Global Antibody-drug Conjugates Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Antibody-drug Conjugates Market Drivers
Figure 15. Antibody-drug Conjugates Market Restraints
Figure 16. Antibody-drug Conjugates Market Trends
Figure 17. Global Antibody-drug Conjugates Sales Market Share by Manufacturer in 2021
Figure 18. Global Antibody-drug Conjugates Revenue Market Share by Manufacturer in 2021
Figure 19. Antibody-drug Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Antibody-drug Conjugates Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Antibody-drug Conjugates Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Antibody-drug Conjugates Sales Market Share by Region (2017-2028)
Figure 23. Global Antibody-drug Conjugates Revenue Market Share by Region (2017-2028)
Figure 24. North America Antibody-drug Conjugates Revenue (2017-2028) & (USD Million)
Figure 25. Europe Antibody-drug Conjugates Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Antibody-drug Conjugates Revenue (2017-2028) & (USD Million)
Figure 27. South America Antibody-drug Conjugates Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Antibody-drug Conjugates Revenue (2017-2028) & (USD Million)
Figure 29. Global Antibody-drug Conjugates Sales Market Share by Type (2017-2028)
Figure 30. Global Antibody-drug Conjugates Revenue Market Share by Type (2017-2028)
Figure 31. Global Antibody-drug Conjugates Price by Type (2017-2028) & (USD/Kg)
Figure 32. Global Antibody-drug Conjugates Sales Market Share by Application (2017-2028)
Figure 33. Global Antibody-drug Conjugates Revenue Market Share by Application (2017-2028)
Figure 34. Global Antibody-drug Conjugates Price by Application (2017-2028) & (USD/Kg)
Figure 35. North America Antibody-drug Conjugates Sales Market Share by Type (2017-2028)
Figure 36. North America Antibody-drug Conjugates Sales Market Share by Application (2017-2028)
Figure 37. North America Antibody-drug Conjugates Sales Market Share by Country (2017-2028)
Figure 38. North America Antibody-drug Conjugates Revenue Market Share by Country (2017-2028)
Figure 39. United States Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Antibody-drug Conjugates Sales Market Share by Type (2017-2028)
Figure 43. Europe Antibody-drug Conjugates Sales Market Share by Application (2017-2028)
Figure 44. Europe Antibody-drug Conjugates Sales Market Share by Country (2017-2028)
Figure 45. Europe Antibody-drug Conjugates Revenue Market Share by Country (2017-2028)
Figure 46. Germany Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Antibody-drug Conjugates Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Antibody-drug Conjugates Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Antibody-drug Conjugates Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Antibody-drug Conjugates Revenue Market Share by Region (2017-2028)
Figure 55. China Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Antibody-drug Conjugates Sales Market Share by Type (2017-2028)
Figure 62. South America Antibody-drug Conjugates Sales Market Share by Application (2017-2028)
Figure 63. South America Antibody-drug Conjugates Sales Market Share by Country (2017-2028)
Figure 64. South America Antibody-drug Conjugates Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Antibody-drug Conjugates Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Antibody-drug Conjugates Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Antibody-drug Conjugates Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Antibody-drug Conjugates Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Antibody-drug Conjugates in 2021
Figure 76. Manufacturing Process Analysis of Antibody-drug Conjugates
Figure 77. Antibody-drug Conjugates Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 抗体薬物複合体受託製造のグローバル市場展望 2023年-2029年：IgG1、IgG2、IgG4
  • 抗体薬物複合体（ADC）の世界市場予測（～2028）：製品別、リンカー種類別、ペイロード種類別、ターゲット別、疾患別、地域別
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22DC3747 )"抗体薬物複合体の世界市場2022：アドセトリス、カドキュラ" (英文：Global Antibody-drug Conjugates Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。